Back to Investors
EHE Ventures

EHE Ventures

Accelerator

EHE Venture Studio is a Manchester-based venture studio backing early-stage AI-driven startups across the UK with capital and operational support.

Portfolio

5

companies


Portfolio companies

D

Deltabase

Deltabase offers an analytics platform that maps corporate culture and workforce dynamics.

NT

NeuWave Technologies

NeuWave Technologies provides AI-powered wave forecasting to address offshore industry bottlenecks.

GW

Good With

Good With provides alternative credit assessment technology for lenders.

SP

Spotlight Pathology

Spotlight Pathology develops artificial intelligence tools to speed up blood cancer diagnosis.

F

Fotenix

Fotenix develops artificial intelligence tools to detect crop disease before symptoms appear.


Team

NV

Neil Vose

CEO of EHE Venture Studio


Recent investments

Seed
£1.0M

River Capital led the EIS funding round, which included backing from EHE Ventures.

"For years, companies have had access to every possible metric about their competitors – except the ones that matter most. Financials and customer metrics are easy to map, but understanding how organisations lead, retain, and inspire people has always been the missing piece. Deltabase fills that gap. We give decision-makers actionable, data-backed evidence of how teams operate, so they can move faster and with more confidence. When you bring clarity to culture, you change how strategy gets delivered."
— Phil Spratt, CEO
Pre-Seed
£550K

The pre-seed round was backed by EHE Ventures, Insurtech Gateway, and QVentures to fund product development and hiring.

"Marine weather errors cost the industry over £1.2 billion a year and that figure’s growing. A single bad forecast can halt operations, with each idle vessel costing £100K–£700K per day depending on asset class, project stage, and insurance liabilities. We’re solving that with precision forecasting that adapts to local conditions in real-time."
— Jana Stella, Founder and CEO
Seed
£200K

The investment was led by EHE Ventures and will be used to accelerate product development and scale operations.

"Credit scores are broken for millions of people. Our platform provides a more accurate picture of someone’s financial behaviour, especially for young adults, new arrivals to the UK, or anyone overlooked by legacy models. This funding allows us to accelerate product development and scale our impact through partnerships with forward-thinking lenders."
— Gabriela Isas, CEO
£425K

EHE Ventures led the round with support from Deepbridge Capital and Lyva Labs to accelerate product development and regulatory approval.

"Spotlight Pathology represents exactly the type of highly innovative company that Deepbridge is privileged to invest in. We initially supported the team through our Seed Enterprise Investment Scheme (SEIS), and are now pleased to back them again through our EIS fund, alongside EHE and Lyva Labs. We look forward to supporting the team as they scale in the exciting field of digital pathology."
— Andrew Round, Investment Director